Chemomab Therapeutics Ltd.

CMMB ·Healthcare, Drug Manufacturers - General
Financial Statements › Balance Sheet
Annual Quarterly

Balance Sheet

Line Item FY2017
Assets
Cash & Equivalents $1.5M
Accounts Receivable $400.0K
Inventory —
Total Current Assets $1.9M
Property, Plant & Equipment —
Goodwill —
Intangible Assets (Excl. Goodwill) —
Total Assets $2.1M
Liabilities
Accounts Payable —
Total Current Liabilities $2.7M
Long-Term Debt —
Total Liabilities $2.7M
Stockholders' Equity
Retained Earnings $-62.9M
Total Stockholders' Equity $-609.0K
← Newer Page 2 of 2 Older →